| Product Code: ETC7650203 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Drug Safety Solutions and Pharmacovigilance Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Drug Safety Solutions and Pharmacovigilance Market - Industry Life Cycle |
3.4 Israel Drug Safety Solutions and Pharmacovigilance Market - Porter's Five Forces |
3.5 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Functionality, 2021 & 2031F |
3.8 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Delivery, 2021 & 2031F |
3.9 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Drug Safety Solutions and Pharmacovigilance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on patient safety and regulatory compliance |
4.2.2 Growing pharmaceutical industry in Israel |
4.2.3 Rising demand for pharmacovigilance services due to globalization and increasing drug approvals |
4.3 Market Restraints |
4.3.1 High implementation costs of drug safety solutions |
4.3.2 Lack of skilled professionals in pharmacovigilance field |
4.3.3 Stringent regulatory requirements and reporting standards |
5 Israel Drug Safety Solutions and Pharmacovigilance Market Trends |
6 Israel Drug Safety Solutions and Pharmacovigilance Market, By Types |
6.1 Israel Drug Safety Solutions and Pharmacovigilance Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Software, 2021- 2031F |
6.1.4 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Services, 2021- 2031F |
6.2 Israel Drug Safety Solutions and Pharmacovigilance Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Standard Form, 2021- 2031F |
6.2.3 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Customized Form, 2021- 2031F |
6.3 Israel Drug Safety Solutions and Pharmacovigilance Market, By Functionality |
6.3.1 Overview and Analysis |
6.3.2 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Adverse Event Reporting Software, 2021- 2031F |
6.3.3 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Drug Safety Audits Software, 2021- 2031F |
6.3.4 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Issue Tracking Software, 2021- 2031F |
6.4 Israel Drug Safety Solutions and Pharmacovigilance Market, By Delivery |
6.4.1 Overview and Analysis |
6.4.2 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By On-Premise Delivery Mode, 2021- 2031F |
6.4.3 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By On-Demand/Cloud-Based (SAAS) Delivery Mode, 2021- 2031F |
6.5 Israel Drug Safety Solutions and Pharmacovigilance Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Biotechnology and Pharmaceuticals, 2021- 2031F |
6.5.3 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Contract Research Organizations (CROS), 2021- 2031F |
6.5.4 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.5 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By KPOs/BPOs, 2021- 2031F |
6.5.6 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.6 Israel Drug Safety Solutions and Pharmacovigilance Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Direct Sales, 2021- 2031F |
6.6.3 Israel Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 Israel Drug Safety Solutions and Pharmacovigilance Market Import-Export Trade Statistics |
7.1 Israel Drug Safety Solutions and Pharmacovigilance Market Export to Major Countries |
7.2 Israel Drug Safety Solutions and Pharmacovigilance Market Imports from Major Countries |
8 Israel Drug Safety Solutions and Pharmacovigilance Market Key Performance Indicators |
8.1 Adverse event reporting accuracy rate |
8.2 Compliance rate with regulatory requirements |
8.3 Time taken to resolve pharmacovigilance incidents |
8.4 Number of new drug approvals requiring pharmacovigilance services |
8.5 Rate of adoption of digital pharmacovigilance tools |
9 Israel Drug Safety Solutions and Pharmacovigilance Market - Opportunity Assessment |
9.1 Israel Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Israel Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Functionality, 2021 & 2031F |
9.4 Israel Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Delivery, 2021 & 2031F |
9.5 Israel Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Israel Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Drug Safety Solutions and Pharmacovigilance Market - Competitive Landscape |
10.1 Israel Drug Safety Solutions and Pharmacovigilance Market Revenue Share, By Companies, 2024 |
10.2 Israel Drug Safety Solutions and Pharmacovigilance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here